Pancuronium Bromide (Hospira, Inc.)


Welcome to the PulseAid listing for the Pancuronium Bromide drug offered from Hospira, Inc.. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Pancuronium Bromide
SUBSTANCE NAME: PANCURONIUM BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-10-11
END MARKETING DATE: 0000-00-00


Pancuronium Bromide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPancuronium Bromide from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2005-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-4646_6e93c25d-3750-46d3-8954-b9489db7c1be
PRODUCT NDC: 0409-4646
APPLICATION NUMBER: ANDA072320

Other PANCURONIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Pancuronium Bromide